Study sheds light on breast cancer drug failure
LONDON (Reuters) - The most commonly used breast cancer drug may cause tumors to spread in a small number of women with low levels of a protein which makes cells stick together, British researchers said on Thursday.<div class="feedflare">
<img src="http://feedproxy.google.com/~f/reuters/scienceNews?d=41" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=KJgTICnn) <img src="http://feedproxy.google.com/~f/reuters/scienceNews?i=6ukgXXEB" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=6ukgXXEB) <img src="http://feedproxy.google.com/~f/reuters/scienceNews?i=yRcf3kLc" border="0"></img> (http://feeds.reuters.com/~f/reuters/scienceNews?a=yRcf3kLc)
</div><img src="http://feedproxy.google.com/~r/reuters/scienceNews/~4/_FHUK0xrabg" height="1" width="1"/>
http://feeds.reuters.com/~r/reuters/scienceNews/~3/_FHUK0xrabg/idUSTRE4B300N20081204